Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., Novick, K. L. M., Sedhom, R., Seigel, C., Stimmel, J., & Bruera, E. (2023). Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology, 41(4), 914–930. https://doi.org/10.1200/jco.22.02198

Lu, C., Ma, H., Song, L., Wang, H., Wang, L., Li, S., Lagana, S. M., Sepulveda, A. R., Hoebe, K., Pan, S. S., Yang, Y.-G., Lentzsch, S., & Mapara, M. Y. (2023). IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease. Journal of Clinical Investigation, 133(3). https://doi.org/10.1172/jci125986

Roh, D. J., Chang, T. R., Kumar, A., Burke, D., Torres, G., Xu, K., Yang, W., Cottarelli, A., Moore, E., Sauaia, A., Hansen, K., Velazquez, A., Boehme, A., Vrosgou, A., Ghoshal, S., Park, S., Agarwal, S., Claassen, J., Connolly, E. S., … Hod, E. (2023). Hemoglobin Concentration Impacts Viscoelastic Hemostatic Assays in ICU Admitted Patients*. Critical Care Medicine, 51(2), 267–278. https://doi.org/10.1097/ccm.0000000000005700

Boone, R. M., Praiss, A. M., Huang, Y., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., St. Clair, C. M., Hershman, D. L., & Wright, J. D. (2023). Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. Gynecologic Oncology, 169, 70–77. https://doi.org/10.1016/j.ygyno.2022.11.022

Joshi, M., Tuanquin, L., Zhu, J., Walter, V., Schell, T., Kaag, M., Kilari, D., Liao, J., Holder, S. L., Emamekhoo, H., Sankin, A., Merrill, S., Zheng, H., Warrick, J., Hauke, R., Gartrel, B., Stein, M., Drabick, J., Degraff, D. J., & Zakharia, Y. (2023). Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. Journal for ImmunoTherapy of Cancer, 11(2), e006551. https://doi.org/10.1136/jitc-2022-006551

Brown, J. R., Eichhorst, B., Hillmen, P., Jurczak, W., Kaźmierczak, M., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Zhou, K., Simkovic, M., Mayer, J., Gillespie-Twardy, A., Ferrajoli, A., Ganly, P. S., Weinkove, R., Grosicki, S., Mital, A., Robak, T., … Shadman, M. (2023). Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine, 388(4), 319–332. https://doi.org/10.1056/nejmoa2211582

Johnson, J. L., Yaron, T. M., Huntsman, E. M., Kerelsky, A., Song, J., Regev, A., Lin, T.-Y., Liberatore, K., Cizin, D. M., Cohen, B. M., Vasan, N., Ma, Y., Krismer, K., Robles, J. T., van de Kooij, B., van Vlimmeren, A. E., Andrée-Busch, N., Käufer, N. F., Dorovkov, M. V., … Cantley, L. C. (2023). An atlas of substrate specificities for the human serine/threonine kinome. Nature, 613(7945), 759–766. https://doi.org/10.1038/s41586-022-05575-3

Mannes, P. Z., Barnes, C. E., Biermann, J., Latoche, J. D., Day, K. E., Zhu, Q., Tabary, M., Xiong, Z., Nedrow, J. R., Izar, B., Anderson, C. J., Villanueva, F. S., Lee, J. S., & Tavakoli, S. (2023). Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury. Proceedings of the National Academy of Sciences, 120(3). https://doi.org/10.1073/pnas.2216458120

Peng, K., Zhang, F., Wang, Y., Sahgal, P., Li, T., Zhou, J., Liang, X., Zhang, Y., Sethi, N., Liu, T., Zhang, H., & Bass, A. J. (2022). Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer. Clinical Cancer Research, 29(1), 197–208. https://doi.org/10.1158/1078-0432.ccr-22-1609

Fu, J., Rust, D., Fang, Z., Jiao, W., Lagana, S., Batal, I., Chen, B., Merl, S., Jones, R., Sykes, M., & Weiner, J. (2022). T cell repertoire profiling in allografts and native tissues in recipients with COVID–19 after solid organ transplantation: Insight into T cell–mediated allograft protection from viral infection. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1056703

Burke, A., Borot, F., Du, X., Churchill, M., Ding, J., Grass, A. M., DeSouza, P., Ali, A. M., & Mukherjee, S. (2022). A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia. Oncogene, 42(1), 26–34. https://doi.org/10.1038/s41388-022-02532-2

Cherng, H. J., Xu, G., Feng, L., Steiner, R., Fayad, L., Strati, P., Nair, R., Nastoupil, L. J., Lee, H. J., Neelapu, S. S., Flowers, C. R., Rodriguez, M., Wang, M., Hagemeister, F., Pinnix, C. C., Ramdial, J., Srour, S., Nieto, Y., Rezvani, K., … Ahmed, S. (2022). Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant. British Journal of Haematology, 200(1), 35–44. Portico. https://doi.org/10.1111/bjh.18441

Wang, Y., Fan, J. L., Melms, J. C., Amin, A. D., Georgis, Y., Barrera, I., Ho, P., Tagore, S., Abril-Rodríguez, G., He, S., Jin, Y., Biermann, J., Hofree, M., Caprio, L., Berhe, S., Khan, S. A., Henick, B. S., Ribas, A., Macosko, E. Z., … Izar, B. (2023). Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nature Genetics, 55(1), 19–25. https://doi.org/10.1038/s41588-022-01268-9

Dioun, S., Chen, L., Melamed, A., Gockley, A., St. Clair, C. M., Hou, J. Y., Khoury‐Collado, F., Hur, C., Elkin, E., Accordino, M., Hershman, D. L., & Wright, J. D. (2022). Dostarlimab for recurrent mismatch repair‐deficient endometrial cancer: A cost‐effectiveness study. BJOG: An International Journal of Obstetrics & Gynaecology, 130(2), 214–221. Portico. https://doi.org/10.1111/1471-0528.17338

Araujo, D., Greystoke, A., Bates, S., Bayle, A., Calvo, E., Castelo-Branco, L., de Bono, J., Drilon, A., Garralda, E., Ivy, P., Kholmanskikh, O., Melero, I., Pentheroudakis, G., Petrie, J., Plummer, R., Ponce, S., Postel-Vinay, S., Siu, L., Spreafico, A., … Seymour, L. (2023). Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Annals of Oncology, 34(1), 48–60. https://doi.org/10.1016/j.annonc.2022.09.158

Austin, J. D., Shelton, E., Crookes, D. M., Tehranifar, P., Neugut, A. I., & Shelton, R. C. (2023). Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer. MDM Policy & Practice, 8(1). https://doi.org/10.1177/23814683231163189

Bukhari, S., Henick, B. S., Winchester, R. J., Lerrer, S., Adam, K., Gartshteyn, Y., Maniar, R., Lin, Z., Khodadadi-Jamayran, A., Tsirigos, A., Salvatore, M. M., Lagos, G. G., Reiner, S. L., Dallos, M. C., Mathew, M., Rizvi, N. A., & Mor, A. (2023). Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. Cell Reports Medicine, 4(1), 100868. https://doi.org/10.1016/j.xcrm.2022.100868

Shabbir, A., Kojadinovic, A., Shafiq, T., & Mundi, P. S. (2023). Targeting RET alterations in cancer: Recent progress and future directions. Critical Reviews in Oncology/Hematology, 181, 103882. https://doi.org/10.1016/j.critrevonc.2022.103882

Lipsky, A. H., & Lamanna, N. (2022). Novel combination approaches with targeted agents in frontline chronic lymphocytic leukemia. Cancer, 129(1), 18–31. Portico. https://doi.org/10.1002/cncr.34510

Zhang, J., McGuinness, J. E., He, X., Jones, T., Silverman, T., Guzman, A., May, B. L., Kukafka, R., & Crew, K. D. (2023). Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women. American Journal of Preventive Medicine, 64(1), 51–60. https://doi.org/10.1016/j.amepre.2022.08.004

Gartrell, R. D., Enzler, T., Kim, P. S., Fullerton, B. T., Fazlollahi, L., Chen, A. X., Minns, H. E., Perni, S., Weisberg, S. P., Rizk, E. M., Wang, S., Oh, E. J., Guo, X. V., Chiuzan, C., Manji, G. A., Bates, S. E., Chabot, J., Schrope, B., Kluger, M., … Saenger, Y. M. (2022). Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. OncoImmunology, 11(1). https://doi.org/10.1080/2162402x.2022.2066767

Lee, P. J., Benz, C. C., Blood, P., Börner, K., Campisi, J., Chen, F., Daldrup-Link, H., De Jager, P., Ding, L., Duncan, F. E., Eickelberg, O., Fan, R., Finkel, T., Furman, D., Garovic, V., Gehlenborg, N., Glass, C., … Yang, M. (2022). NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health. Nature Aging, 2(12), 1090–1100. https://doi.org/10.1038/s43587-022-00326-5

Meacham, L. R., Pecker, L. H., Gee, B., & Mishkin, A. (2022). Incorporating gonadal health counseling into pediatric care of sickle cell patients. Hematology, 2022(1), 442–449. https://doi.org/10.1182/hematology.2022000382

Cogan, J. C., Raghunathan, R. R., Beauchemin, M. P., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022). New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer. JNCI: Journal of the National Cancer Institute, 114(12), 1698–1705. https://doi.org/10.1093/jnci/djac170

Chakraborty, R., Rybicki, L., Wei, W., Valent, J., Faiman, B. M., Samaras, C. J., Anwer, F., & Khorana, A. A. (2022). Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score. Blood, 140(23), 2443–2450. https://doi.org/10.1182/blood.2022015727

Brown, J. R., Eichhorst, B., Hillmen, P., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Kaźmierczak, M., Jurczak, W., Zhou, K., Šimkovič, M., Mayer, J., Gillespie-Twardy, A. L., Ferrajoli, A., Ganly, P. S., Weinkove, R., Grosicki, S., Mital, A., Robak, T., … Shadman, M. (2022). Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results from Final Analysis of ALPINE Randomized Phase 3 Study. Blood, 140(Supplement 2), LBA-6-LBA-6. https://doi.org/10.1182/blood-2022-171538

Cicero, K. I., Joffe, M., Patel, M., Chiuzan, C., Pentz, A., Ruff, P., Lentzsch, S., Leng, S., Jacobson, J. S., Rebbeck, T. R., & Neugut, A. I. (2022). Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiology, Biomarkers & Prevention, 31(12), 2192–2198. https://doi.org/10.1158/1055-9965.epi-22-0525

Chu, C. M. J., Modi, H., Ellis, C., Krentz, N. A. J., Skovsø, S., Zhao, Y. B., Cen, H., Noursadeghi, N., Panzhinskiy, E., Hu, X., Dionne, D. A., Xia, Y. H., Xuan, S., Huising, M. O., Kieffer, T. J., Lynn, F. C., & Johnson, J. D. (2022). Dynamic Ins2 Gene Activity Defines β-Cell Maturity States. Diabetes, 71(12), 2612–2631. https://doi.org/10.2337/db21-1065

Thomas, A. S., Kwon, W., Horowitz, D. P., Bates, S. E., Fojo, A. T., Manji, G. A., Schreibman, S., Schrope, B. A., Chabot, J. A., & Kluger, M. D. (2022). Long‐term follow‐up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer. Journal of Surgical Oncology, 126(8), 1442–1450. Portico. https://doi.org/10.1002/jso.27085

Mucha, B., Qie, S., Bajpai, S., Tarallo, V., Diehl, J. N., Tedeschi, F., Zhou, G., Gao, Z., Flashner, S., Klein-Szanto, A. J., Hibshoosh, H., Masataka, S., Chajewski, O. S., Majsterek, I., Pytel, D., Hatzoglou, M., Der, C. J., Nakagawa, H., Bass, A. J., … Diehl, J. A. (2022). Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34402-6

Ro, V., Jones, T., Silverman, T., McGuinness, J. E., Guzman, A., Amenta, J., Kukafka, R., & Crew, K. D. (2022). Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09900-x

Chaudhary, K. R., Kinslow, C. J., Cheng, H., Silva, J. M., Yu, J., Wang, Tony. J., Hei, T. K., Halmos, B., & Cheng, S. K. (2022). Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-14448-8

Schvartzman, J. M., & Intlekofer, A. M. (2022). D-2HG comes out of its shell: Metabolic effects on the immune environment. Molecular Cell, 82(23), 4407–4409. https://doi.org/10.1016/j.molcel.2022.11.005

Li, Y., Wu, Y., Federzoni, E. A., Wang, X., Dharmawan, A., Hu, X., Wang, H., Hawley, R. J., Stevens, S., Sykes, M., & Yang, Y.-G. (2022). CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals. ELife, 11. CLOCKSS. https://doi.org/10.7554/elife.73677

Oren, D., DeFilippis, E. M., Lotan, D., Clerkin, K. J., Fried, J., Reshef, R., Fernandez, H., Lin, E., Amengual, J., Sayer, G., Uriel, N., & Raikhelkar, J. K. (2022). Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD. JACC: CardioOncology, 4(5), 713–716. https://doi.org/10.1016/j.jaccao.2022.09.002

Kao, D. D., Ferrandino, R. M., Bauml, J. M., Marshall, D. C., Bakst, R., Roof, S., Park, Y.-H. A., & Sigel, K. M. (2022). Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck. Oral Oncology, 135, 106216. https://doi.org/10.1016/j.oraloncology.2022.106216

Freedman, R. A., Ko, N. Y., Lederman, R. I., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Odai-Afotey, A., Kantor, O., Hershman, D. L., Crew, K. D., & Keating, N. L. (2022). Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Research and Treatment, 196(3), 623–633. https://doi.org/10.1007/s10549-022-06752-8

Laise, P., Stanifer, M. L., Bosker, G., Sun, X., Triana, S., Doldan, P., La Manna, F., De Menna, M., Realubit, R. B., Pampou, S., Karan, C., Alexandrov, T., Kruithof-de Julio, M., Califano, A., Boulant, S., & Alvarez, M. J. (2022). A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03663-8

Ascierto, P. A., Agarwala, S. S., Blank, C., Caracò, C., Carvajal, R. D., Ernstoff, M. S., Ferrone, S., Fox, B. A., Gajewski, T. F., Garbe, C., Grob, J.-J., Hamid, O., Krogsgaard, M., Lo, R. S., Lund, A. W., Madonna, G., Michielin, O., Neyns, B., Osman, I., … Thurin, M. (2022). Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy). Journal of Translational Medicine, 20(1). https://doi.org/10.1186/s12967-022-03592-4

Watabayashi, K. K., Bell-Brown, A., Kreizenbeck, K., Egan, K., Lyman, G. H., Hershman, D. L., Arnold, K. B., Bansal, A., Barlow, W. E., Sullivan, S. D., & Ramsey, S. D. (2022). Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07835-4

Mullangi, S., Aviki, E. M., & Hershman, D. L. (2022). Reexamining Social Determinants of Health Data Collection in the COVID-19 Era. JAMA Oncology, 8(12), 1736. https://doi.org/10.1001/jamaoncol.2022.4543

Cochran, S. J., Acosta, L., Divjan, A., Lemons, A. R., Rundle, A. G., Miller, R. L., Sobek, E., Green, B. J., Perzanowski, M. S., & Dannemiller, K. C. (2022). Spring is associated with increased total and allergenic fungal concentrations in house dust from a pediatric asthma cohort in New York City. Building and Environment, 226, 109711. https://doi.org/10.1016/j.buildenv.2022.109711

Xu, J. J., Chalk, A. M., Wall, M., Langdon, W. Y., Smeets, M. F., & Walkley, C. R. (2022). Srsf2P95H/+ co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice. Leukemia, 36(12), 2883–2893. https://doi.org/10.1038/s41375-022-01727-6

Sykes, M., & Sachs, D. H. (2022). Progress in xenotransplantation: overcoming immune barriers. Nature Reviews Nephrology, 18(12), 745–761. https://doi.org/10.1038/s41581-022-00624-6

Wei, A. Z., Maniar, A. B., & Carvajal, R. D. (2022). New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma. Cancer Gene Therapy, 29(12), 1819–1826. https://doi.org/10.1038/s41417-022-00443-8

Jones, T., Silverman, T., Guzman, A., McGuinness, J. E., Trivedi, M. S., Kukafka, R., & Crew, K. D. (2022). Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers. BMC Medical Informatics and Decision Making, 22(1). https://doi.org/10.1186/s12911-022-01954-y

AlQahtani, M., Du, X., Bhattacharyya, S., Alawadi, A., Al Mahmeed, H., Al Sayed, J., Justman, J., El-Sadr, W. M., Hidary, J., & Mukherjee, S. (2022). Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-12543-4

Anandakumaran, P. N., Ayers, A. G., Muranski, P., Creusot, R. J., & Sia, S. K. (2022). Rapid video-based deep learning of cognate versus non-cognate T cell-dendritic cell interactions. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-021-04286-5

Dioun, S., Chen, L., Gockley, A., Melamed, A., Clair, C. S., Hou, J., Khoury-Collado, F., Elkin, E., Hershman, D., & Wright, J. (2022). 31/#204 Cost-effectiveness of hysterectomy at the time of risk-reducing bilateral salpingooophorectomy for patients with BRCA1 mutations. Featured Printed Posters (Poster Rounds with the Professors). https://doi.org/10.1136/ijgc-2022-igcs.75

Moodley, Y., Govender, K., van Wyk, J., Reddy, S., Ning, Y., Wexner, S., Stopforth, L., Bhadree, S., Naidoo, V., Kader, S., Cheddie, S., Neugut, A. I., & Kiran, R. P. (2022). Predictors of treatment refusal in patients with colorectal cancer: A systematic review. Seminars in Oncology, 49(6), 456–464. https://doi.org/10.1053/j.seminoncol.2023.01.002